LEK Polska Implements Scala
Added: (Tue Apr 16 2002)
Pressbox (Press Release) -
Eastern European pharmaceutical leader selects Scala due to its solid experience in the pharmaceutical industry worldwide
16 April 2002: LEK Polska Sp. z o.o., has signed a contract to implement Scala’s standard ERP software package in Poland in order to maintain the company’s further expansion.
“The previous system, which contained a set of various, loosely integrated, book keeping and logistic modules, was unable to process large amounts of data and didn’t meet the new requirements we have because of our ever expanding activity,” says Bojan Jagodič, Financial Director at LEK Polska. “The quality and quantity of the information that the old system delivered was no longer sufficient to manage a company efficiently and we therefore decided to purchase new ERP software early last year. By way of elimination we selected Scala, relying on their references and experience in the pharmaceutical market”.
LEK Polska is a subsidiary of the Slovenian company, LEK Pharmaceutical and Chemical Company d.d., a medium-sized manufacturer of drugs, over-the-counter medications and veterinary products. LEK d.d. has been present in Poland for over 35 years, while LEK Polska was established in 1991 and has since managed to build a strong market position. In October 2001 LEK Polska acquired Argon S.A., a Polish drug manufacturer, thus extending its product offerings and confirming its market leadership.
LEK Polska has purchased Scala’s financial modules including fixed assets management, logistics and manufacturing. One of the main requirements was that any system had to provide concurrent user access as well as remote access to the whole system, hosted on a server at the Pruszków headquarters, from the production plant in Łódź. LEK Polska also selected Crystal Reports software as an additional tool for generating reports.
The project started in early October 2001. “The book keeping and logistics modules were implemented first and it proved to be a great challenge to complete the first part of the project within a three-month period, because of LEK’s particularly complicated company structure,” says Piotr Krzysztoporski, Scala’s consultant who supervised the first implementation stage. “Every step of the implementation was carried out according to our standard Signature implementation methodology and system parameters and work procedures were set up following consultation with LEK Polska representatives. Two crucial requirements that couldn’t be met in the standard software processes were defined during the analysis phase. The requirements came from Polish legislation for drug trading and together we worked out that they could be met through Scala’s Automation Manager. Once the initial testing was done the system went live and they successfully closed their first month of operation in February this year.”
Due to its large scope, the project was split into several stages. At the moment, Scala’s financial and logistics processes are being implemented at ARGON Łódź, a separate company co-operating with LEK Sp. z.o.o. The implementation of the manufacturing processes, planned for later this year, will be the next stage of the project.
Jagodič concludes: “This is not our first encounter with Scala’s products - two other companies related to LEK already use Scala software. Selecting the Scala system was not just a simple selection of an ERP system, but a decision to start a long-term relationship with Scala as a company.”
# # #
Notes to Editors
About LEK Polska Sp. z o.o.
LEK Polska Sp. z o.o. is a subsidiary office of the Slovenian company, LEK Pharmaceutical and Chemical Company d.d. The company aims first and foremost at drug development, production and sales. LEK manufactures self-treatment specimens, cosmetic products, veterinary medications and medical equipment. The company has been present on the Polish market for over 35 years. LEK Polska was established in 1991. Sales in 2001 amounted to PLN 222 million (over 60 million euro).
The LEK group contains 16 companies located, among others, in Poland, USA, Croatia, the Czech Republic and the Russian Federation.
About Scala Business Solutions
Scala Business Solutions creates collaborative ERP software – integrating Internet technology and traditional ERP functionality – to make global business simple. With Scala, global companies can fully integrate all their ERP systems anywhere in the world, whether in a subsidiary, division or headquarters, and extending to their partners and suppliers.
Scala’s collaborative ERP software makes it possible for global companies to meet the requirements for advanced e-business as well as use a standard ERP product for managing traditional business processes. This enables them to gain measurable benefits from trading electronically, building a private exchange or global portal, or optimising the supply chain.
From offices in Europe, North America and the Far East, and through its network of partners and dealers, Scala delivers software and services that are available in over 30 languages in more than 100 countries.
Scala is listed on the Euronext Amsterdam Stock Exchange (symbol: SCALA). 2001 revenue was USD 70.6 million.
Visit Scala’s website at www.scala.net for press information including press releases, information for investors, and company and product information.
© 2002 Scala Business Solutions, NV. All rights reserved. Scalaź is a registered trademark. Other trademarks or registered trademarks are the property of their respective owners.